Veracyte | VCYT - 贷款资金



金融业
股票价格
USD
资产
USD 1.49B
现金及等价物
USD 299.52M
销售成本
USD 42.19M
流动资产
USD 574.78M
流动负债
USD 62.74M
债务
USD 39.33M
EBIT
USD 23.96M
EBITDA
USD 43.96M
员工
824
EPS每股收益
USD 0.54
股本和储备
USD 1.39B
销售毛利
USD 108.55M
债务利息支出
USD 2K
利息收入
USD 3.48M
贷款资金
USD 0
市值
USD 3.13B
净收入
USD 25.49M
营业费用
USD 126.36M
营业利润
USD 23.96M
普通股股本
USD 79.79M
PE价格收益
42.77
税前利润
USD 26.52M
销售收入
USD 150.32M
销售和管理费用
USD 55.71M
股票
USD 22.66M
贸易债权人
USD 8.02M
应收帐款人
USD 54.18M


贷款资金 更改 日
Agenus USD 153.98M 15.68M 2026-03
Agilent USD 3.64B 594M 2026-06
Arrowhead Research USD 824.07M 401.34M 2026-06
Bruker USD 1.81B 151.8M 2026-06
Heron Therapeutics USD 140.64M 975K 2025-12
Illumina USD 1.49B 1000K 2026-06
Intrexon USD 0 198.67M 2024-06
Karyopharm Therapeutics USD 264.49M 13.73M 2026-03
Laboratory Of America USD 5.92B 23.3M 2026-06
Ligand Pharmaceuticals USD 446.9M 704K 2026-03
Myriad Genetics USD 120.7M 400K 2026-06
Rigel Pharmaceuticals USD 0 0 2024-09
Roche Holding CHF 25.22B 2.21B 2026-06
Sangamo BioSciences USD 0 0 2022-06
Siemens EUR 41.32B 199M 2026-06
Sonic Healthcare AUD 4.19B 333.39M 2024-12
Thermo Fisher Scientific USD 39.18B 890M 2026-06
Veracyte USD 0 0 2025-03
Waters USD 5.09B 129M 2026-06